Skip to Main Content

Targeting macular degeneration

Yale Medicine Magazine, 2001 - Autumn

Contents

Macular degeneration, caused by the deterioration of the central portion of the retina called the macula, affects an estimated one-third of the over-65 population. Now, with a $1 million gift from Foresight Inc. and $1 million in matching funds raised by Yale, the Department of Ophthalmology and Visual Science is on its way to establishing a center to address problems in retinal functioning. The funding will be put toward the $5 million cost of establishing a center to study the cellular and molecular biology and physiology of the development of the retina.

Foresight Inc. is a Connecticut-based charitable foundation. It was founded in 1968 by patients treated by Yale ophthalmologists.

Previous Article
Sleep apnea and stroke
Next Article
Case of hide and seek?